APG Asset Management US Inc. Decreases Stake in UnitedHealth Group Incorporated (NYSE:UNH)

APG Asset Management US Inc. decreased its position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 26.3% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 19,083 shares of the healthcare conglomerate's stock after selling 6,826 shares during the period. APG Asset Management US Inc.'s holdings in UnitedHealth Group were worth $9,653,000 as of its most recent SEC filing.

Several other institutional investors have also recently made changes to their positions in the company. Geode Capital Management LLC raised its position in UnitedHealth Group by 1.6% in the fourth quarter. Geode Capital Management LLC now owns 19,956,219 shares of the healthcare conglomerate's stock valued at $10,068,869,000 after purchasing an additional 319,515 shares during the period. Norges Bank acquired a new stake in shares of UnitedHealth Group during the fourth quarter valued at about $6,375,744,000. Franklin Resources Inc. lifted its holdings in shares of UnitedHealth Group by 10.7% in the 4th quarter. Franklin Resources Inc. now owns 8,923,770 shares of the healthcare conglomerate's stock worth $4,514,178,000 after acquiring an additional 861,854 shares during the last quarter. Bank of New York Mellon Corp increased its holdings in UnitedHealth Group by 0.5% in the 4th quarter. Bank of New York Mellon Corp now owns 7,931,478 shares of the healthcare conglomerate's stock valued at $4,012,218,000 after purchasing an additional 36,394 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. lifted its stake in UnitedHealth Group by 3.0% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 6,223,331 shares of the healthcare conglomerate's stock worth $3,148,134,000 after purchasing an additional 182,361 shares in the last quarter. Hedge funds and other institutional investors own 87.86% of the company's stock.

Analyst Ratings Changes

Several equities analysts recently issued reports on the company. HSBC raised UnitedHealth Group from a "hold" rating to a "buy" rating and set a $595.00 target price on the stock in a research note on Friday, January 10th. KeyCorp reissued an "overweight" rating and issued a $650.00 price objective on shares of UnitedHealth Group in a research note on Friday, January 17th. Truist Financial increased their target price on shares of UnitedHealth Group from $610.00 to $660.00 and gave the stock a "buy" rating in a report on Friday. Piper Sandler cut their price objective on UnitedHealth Group from $605.00 to $600.00 and set an "overweight" rating on the stock in a research report on Thursday, January 2nd. Finally, Hsbc Global Res raised UnitedHealth Group from a "hold" rating to a "strong-buy" rating in a research note on Friday, January 10th. Twenty-one analysts have rated the stock with a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of "Buy" and a consensus price target of $632.85.

Insider Activity

In other news, Director Timothy Patrick Flynn acquired 1,000 shares of the company's stock in a transaction on Friday, January 17th. The shares were bought at an average cost of $511.57 per share, with a total value of $511,570.00. Following the purchase, the director now owns 4,500 shares of the company's stock, valued at $2,302,065. This represents a 28.57 % increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 0.33% of the company's stock.

UnitedHealth Group Stock Up 0.8 %

Shares of NYSE UNH traded up $4.70 during mid-day trading on Friday, reaching $599.10. The company had a trading volume of 6,117,814 shares, compared to its average volume of 4,344,668. The stock has a market cap of $548.00 billion, a P/E ratio of 38.65, a PEG ratio of 1.37 and a beta of 0.61. UnitedHealth Group Incorporated has a 52-week low of $438.50 and a 52-week high of $630.73. The firm has a 50 day simple moving average of $512.87 and a two-hundred day simple moving average of $541.80. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, beating analysts' consensus estimates of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The business had revenue of $100.81 billion for the quarter, compared to analysts' expectations of $101.60 billion. The company's quarterly revenue was up 6.8% on a year-over-year basis. During the same period in the previous year, the company posted $5.83 EPS. Sell-side analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were given a dividend of $2.10 per share. The ex-dividend date was Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a yield of 1.40%. UnitedHealth Group's payout ratio is 54.19%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.